### ü´Å Critical Care Medicine: Septic Shock Vasopressor Therapy

#### ‚úÖ True Statements
1. In **septic shock**, the **2021 Surviving Sepsis Campaign guidelines** recommend an initial **30 mL/kg bolus of crystalloid fluid** within the first 3 hours of resuscitation.  
2. If patients with **septic shock** remain **volume responsive** after the initial bolus, **additional fluid resuscitation** is indicated.  
3. A **passive leg raise test** is a preferred **dynamic assessment** of **volume responsiveness** in septic shock.  
4. In **septic shock** that is **no longer fluid responsive** and remains **hypotensive**, **norepinephrine** is the recommended **first-line vasopressor**.  
5. **Norepinephrine** has **Œ±-adrenergic effects** that cause **peripheral vasoconstriction** and **Œ≤1-adrenergic effects** that increase **ventricular inotropy** without significantly increasing **heart rate**.  
6. **Dobutamine** is the first choice for **cardiogenic shock without hypotension**, not for isolated septic shock with normal cardiac function.  
7. **Dopamine** carries an increased risk of **arrhythmia and death** compared with norepinephrine and is **not recommended** in septic shock except in select patients with **clinically significant bradycardia**.  
8. **Vasopressin** is a **second-line vasopressor** in septic shock and may be **added to norepinephrine** in persistent cases.  
9. **Vasopressin** acts primarily on **V1 receptors** (smooth muscle contraction) and **V2 receptors** (antidiuretic effect).  
10. In **refractory septic shock**, **vasopressin may be added to norepinephrine** to support blood pressure.  

#### üí¨ Extra
1. Colloid albumin is not recommended for initial resuscitation due to cost and lack of additional benefit compared with crystalloids.  
3. Static measures (e.g., central venous pressure) are less reliable than dynamic measures like **passive leg raise** for fluid responsiveness.  
4. **Epinephrine** may be added if norepinephrine and vasopressin together are insufficient to control septic shock.  

#### üè∑Ô∏è Tags
#CriticalCare #Sepsis #SepticShock #Vasopressor #Norepinephrine #Vasopressin #Dobutamine #Dopamine #FluidResuscitation  

#### üìö Reference
Hamzaoui O, Shi R. Early norepinephrine use in septic shock. *J Thorac Dis*. 2020;12:S72-7. PMID: 32148928 doi:10.21037/jtd.2019.12.50  

#### üÜî Question ID
CCMCQ24014  

#### üïí Last Updated
February 2025  

---

#### üìñ Related Text
MKSAP 19: Critical Care Medicine ‚Äî Common ICU Conditions, Sepsis, Management of Sepsis, Initial Resuscitation

---

### üìò Related Text Derivations

#### ‚úÖ True Statements
1. **Sepsis** can impair **preload** (capillary leak), **cardiac contractility**, and **vascular tone**, leading to **shock** with **profound hypotension**.  
2. The **Surviving Sepsis Campaign** recommends an initial **30 mL/kg crystalloid fluid bolus** within the **first 3 hours** for **sepsis-induced hypoperfusion or shock**.  
3. The **1-hour sepsis bundle** recommends starting the fluid bolus **within the first hour of presentation**.  
4. **Crystalloid solutions** are preferred over **colloid albumin** due to cost and lack of additional benefit.  
5. **Dynamic measures** such as the **passive leg raise test** are effective in assessing adequacy of fluid resuscitation.  
6. When **hypotension persists** despite initial fluids, **norepinephrine** is the first-line vasopressor.  
7. A **mean arterial pressure (MAP) target of 60‚Äì65 mm Hg** is generally recommended for septic shock resuscitation.  
8. In patients with **chronic hypertension**, **higher MAP targets** may reduce the risk of **kidney replacement therapy**.  
9. If **norepinephrine is insufficient**, **vasopressin** can be added.  
10. **Epinephrine** may be added for persistent septic shock despite **norepinephrine and vasopressin**.  
11. **Dobutamine** may be used in **septic shock with cardiogenic features**, or **epinephrine alone** is also reasonable.  
12. **Dopamine** is not recommended in septic shock due to **higher risks of tachyarrhythmia and death**, except in **bradycardic patients**.  
13. If **lactate >2 mmol/L**, it should be **rechecked within 2‚Äì4 hours** to monitor improvement.  

#### üí¨ Extra
1. Pathophysiology of septic shock involves all three hemodynamic domains: preload, contractility, and afterload.  
7. A MAP of 60‚Äì65 mm Hg balances perfusion and risk of vasopressor overuse; higher MAPs are reserved for select hypertensive patients.  
13. Lactate is a marker of tissue hypoperfusion and guides adequacy of resuscitation.  

#### üè∑Ô∏è Tags
#Sepsis #SepticShock #MAP #Norepinephrine #Vasopressin #Epinephrine #Dobutamine #Dopamine #FluidResuscitation #LactateMonitoring  

---

#### üóæ Supplemental Tables

<table>
  <caption><strong>Selection of Vasopressors and Inotropes</strong></caption>
  <thead>
    <tr>
      <th>Medication</th>
      <th>Type of Shock</th>
      <th>Receptor Target</th>
      <th>Primary Effect</th>
      <th>Comments</th>
    </tr>
  </thead>
  <tbody>
    <tr>
      <td>Angiotensin II</td>
      <td>Distributive</td>
      <td>AT II</td>
      <td>‚Üë SVR</td>
      <td>Role still being defined</td>
    </tr>
    <tr>
      <td>Dobutamine (inotrope)</td>
      <td>Cardiogenic, Distributive</td>
      <td>Œ≤<sub>1</sub>, Œ≤<sub>2</sub></td>
      <td>‚Üë Inotropy</td>
      <td>First choice for cardiogenic shock without hypotension; may be added to norepinephrine for septic shock with depressed cardiac function</td>
    </tr>
    <tr>
      <td>Milrinone (inotrope)</td>
      <td>Cardiogenic</td>
      <td>PDE3 (inhibitor)</td>
      <td>‚Üë Inotropy</td>
      <td>Alternative agent in cardiogenic shock refractory to other agents</td>
    </tr>
    <tr>
      <td>Dopamine (high-dose)</td>
      <td>Cardiogenic</td>
      <td>D, Œ±<sub>1</sub>, Œ≤<sub>1</sub></td>
      <td>‚Üë SVR, ‚Üë Inotropy</td>
      <td>Associated with increased mortality compared with norepinephrine in distributive shock; use only in severe bradycardia in septic shock</td>
    </tr>
    <tr>
      <td>Dopamine (low-dose)</td>
      <td>Cardiogenic</td>
      <td>D, Œ≤<sub>1</sub></td>
      <td>‚Üë Inotropy, ‚Üë HR</td>
      <td>Not recommended to augment renal blood flow</td>
    </tr>
    <tr>
      <td>Epinephrine</td>
      <td>Cardiogenic, Distributive, Hypovolemic</td>
      <td>Œ±<sub>1</sub>, Œ±<sub>2</sub>, Œ≤<sub>1</sub>, Œ≤<sub>2</sub></td>
      <td>‚Üë SVR, ‚Üë Inotropy</td>
      <td>First choice for anaphylactic shock; may be added to norepinephrine and vasopressin in persistent septic shock; may be used as a single agent in septic shock with depressed cardiac function</td>
    </tr>
    <tr>
      <td>Norepinephrine</td>
      <td>Cardiogenic, Distributive, Hypovolemic</td>
      <td>Œ±<sub>1</sub>, Œ±<sub>2</sub>, Œ≤<sub>1</sub></td>
      <td>‚Üë SVR, ‚Üë Inotropy</td>
      <td>First choice in cardiogenic, distributive, and hypovolemic shock</td>
    </tr>
    <tr>
      <td>Phenylephrine</td>
      <td>Distributive</td>
      <td>Œ±<sub>1</sub></td>
      <td>‚Üë SVR</td>
      <td>Alternative agent in distributive shock when tachyarrhythmias preclude use of first-line agents</td>
    </tr>
    <tr>
      <td>Vasopressin</td>
      <td>Distributive, Hypovolemic</td>
      <td>V</td>
      <td>‚Üë SVR</td>
      <td>May be added to norepinephrine in persistent septic shock; no role in other shock states</td>
    </tr>
  </tbody>
</table>

<p><em>AT II = angiotensin type II; D = dopamine; HR = heart rate; PDE3 = phosphodiesterase 3; SVR = systemic vascular resistance; V = vasopressin.</em></p>

---

#### ‚úÖ True Statements (from Table: Selection of Vasopressors and Inotropes)
1. **Dobutamine** is the **first choice for cardiogenic shock without hypotension** and may be **added to norepinephrine** for **septic shock with depressed cardiac function**.  
2. **Milrinone** is an **alternative inotrope** for **cardiogenic shock refractory** to other agents.  
3. **High-dose dopamine** increases **mortality** compared with **norepinephrine** in distributive shock and should be reserved for **severe bradycardia in septic shock**.  
4. **Low-dose dopamine** is **not recommended** to augment **renal blood flow**.  
5. **Epinephrine** is the **first choice for anaphylactic shock** and may be **added to norepinephrine and vasopressin** in persistent septic shock; it can also be used alone in septic shock with depressed cardiac function.  
6. **Norepinephrine** is the **first-line vasopressor** for **cardiogenic, distributive, and hypovolemic shock**.  
7. **Phenylephrine** is an **alternative vasopressor** for **distributive shock** when **tachyarrhythmias** limit use of first-line agents.  
8. **Vasopressin** may be **added to norepinephrine** in **persistent septic shock**, but it has **no role in other shock states**.  
9. The role of **angiotensin II** in distributive shock is **still being defined**.  

#### üè∑Ô∏è Tags
#CriticalCare #Sepsis #SepticShock #Vasopressors #Inotropes #Dobutamine #Milrinone #Dopamine #Epinephrine #Norepinephrine #Phenylephrine #Vasopressin #AngiotensinII
